Using Transcranial Magnetic Stimulation to Treat Repetitive Behaviors in Autism
Official title: Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Run by Stanford University · NCT04532424 · Data updated 2026-11-12
This study is testing if a non-invasive brain treatment can help reduce repetitive behaviors in people with Autism Spectrum Disorder who haven't had success with other treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 45 Years |
| Sex | All |
| Enrollment | 67 (estimated) |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Stanford, California) |
| Status | Recruiting |
| Started | January 4, 2021 |
| Main results expected | December 1, 2029 |
| Study ends | December 1, 2029 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT04532424 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 12 to 45 with a diagnosis of Autism Spectrum Disorder who have not responded to or tolerated two prior treatments.
✕Probably not a fit
Patients with contraindications for TMS, such as a history of seizures or significant sensory impairments, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of theta-burst transcranial magnetic stimulation (TMS) in reducing restricted and repetitive behaviors in individuals diagnosed with Autism Spectrum Disorder (ASD), including Asperger's Syndrome. Participants aged 12 to 45 who have not responded to or tolerated two previous treatments will undergo TMS sessions. The study aims to assess changes in behavior through clinical assessments and questionnaires completed by reliable informants. The approach focuses on a non-invasive method to potentially improve the quality of life for those affected by ASD.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce repetitive behaviors in individuals with Autism Spectrum Disorder, enhancing their daily functioning and quality of life.
How similar studies have gone: While the use of TMS in treating various conditions is being explored, this specific application for restricted and repetitive behaviors in ASD is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria. 1. Diagnosis of Autism Spectrum Disorder (ASD) 2. Meet criteria for Autism Spectrum Disorder (ASD) on clinical assessments (ADOS-2 or CARS if conducted remotely \& ADI-R) 3. Aged between 12-45 years old 4. Have a reliable informant who can complete relevant questionnaires 5. Have DARB scores which indicate high levels (50% or above) of RRB on one of the following domains: Insistence on Sameness, Obsessive Compulsive Behaviors, and Unusual Interests Exclusion criteria. 1. Any contraindications for TMS e.g. history of seizures other than clear substance-induced/fever-induced seizures with neurologist note or normal clean EEG and no seizure in at least 12 months prior to enrollment. 2. Pregnancy. 3. Any current or past history of any physical condition which in the investigator's opinion might put the subject at risk or interfere with study results interpretation. 4. Active substance use (\<1 week) or intoxication verified by toxicology screen--of cocaine, amphetamines, benzodiazepines. 5. Showing symptoms of withdrawal from alcohol or benzodiazepines. 6. DSM-5 diagnosis of bipolar disorder or a psychotic disorder e.g. schizophrenia. 7. Significant sensory impairments such as blindness or deafness. 8. Current severe insomnia (must sleep a minimum of 4 hours the night before stimulation). 9. Not willing to cooperate with the TMS procedures. 10. Currently taking Clozapine or another medication that the PI determines increases the risk of TMS or may disrupt the efficacy. 11. A motor threshold that is too high to allow safe/tolerable treatment. 12. Conditions that increase the risk for COVID-19 (in accordance with university guidelines).
Where it's running
-
Stanford University
Stanford, California, United States Recruiting
Study contacts
- Principal investigator: Antonio Y. Hardan, MD — Stanford University
- Study coordinator: Briana Hernandez
- Email: autismdd@stanford.edu
- Phone: (650) 736-1235
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A program to improve social skills in adults with autism
This study is trying out a new program called TUNE In to see if it can help adults with autism improve their social skills and feel more comfortable in everyday situations.
-
Supplementation therapy for anxiety and depression in autistic individuals
This study is testing if a supplement called PEA can help reduce anxiety and depression in young adults with Level 1 Autism Spectrum Disorder who haven't found relief with other treatments.
-
AdiaVita and glutathione for autism in kids and teens
This study tests whether adding AdiaVita (cord-blood stem cells and exosomes) to glutathione helps improve ASD symptoms in children and other participants compared with glutathione alone.
-
Online test of BlinkLab Dx1 for autism in kids aged 2–11
This study tests whether the BlinkLab Dx1 smartphone app can help identify autism in children aged 2 to 11 by comparing app-based measurements with prior clinical diagnoses.
-
Trauma‑Focused Cognitive Behavioral Therapy adapted for autistic children and teens (pilot implementation)
This pilot will try TF‑CBT adapted for autistic children and teens with trauma-related symptoms to see if community mental health clinicians can deliver it and families find it acceptable.
-
CRUSH curriculum for romance and sexual health for autistic young adults
This project will try the CRUSH program—a group course plus one-to-one coaching—to teach sexual health and dating skills to autistic adults ages 18 to 30.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.